[1] Reddy, Vivek, et al. “Atrial fibrillation and hyperthyroidism: A literature review.” Indian Heart Journal, Vol. 69,
No. 4, 2017, pp. 545-50.
[2] Ross, Douglas S., et al. “2016 American thyroid association guidelines for diagnosis and management of
hyperthyroidism and other causes of thyrotoxicosis.” Thyroid, Vol. 26, No. 10, 2016, pp. 1343-1421.
[3] Cinar, Nese, and Alper Gurlek. “Association between novel adipocytokines adiponectin, vaspin, visfatin, and
thyroid: An experimental and clinical update.” Endocrine Connections, Vol. 2, No. 4, 2013, pp. R30-R38.
[4] Aydogan, Berna İmge, and Mustafa Sahin. “Adipocytokines in thyroid dysfunction.” ISRN Inflammation, Vol.
2013, 2013.
[5] Knudsen, Nils, et al. “Small differences in thyroid function may be important for body mass index and the
occurrence of obesity in the population.” The Journal of Clinical Endocrinology & Metabolism, Vol. 90, No. 7,
2005, pp. 4019-24.
[6] Hotamisligil, Gökhan S. “Inflammation and metabolic disorders.” Nature 444.7121 (2006): 860-867.
Al-Hindawi Sahar H Int J Med Res Health Sci 2018, 7(1): 40-47
46
[7] Ouchi, Noriyuki, et al. “Adipokines in inflammation and metabolic disease.” Nature Reviews Immunology, Vol.
11, No. 2, 2011, pp. 85-97.
[8] Azamar-Llamas, Daniel, et al. “Adipokine contribution to the pathogenesis of osteoarthritis.” Mediators of
Inflammation, Vol. 2017, 2017.
[9] Parimisetty, Avinash, et al. “Secret talk between adipose tissue and central nervous system via secreted factors-an
emerging frontier in the neurodegenerative research.” Journal of Neuroinflammation, Vol. 13, No. 1, 2016, p. 67.
[10] Pathak, Nitya N., et al. “Anti-inflammatory and chondroprotective effects of atorvastatin in a cartilage explant
model of osteoarthritis.” Inflammation Research, Vol. 64, No. 3-4, 2015, pp. 161-69.
[11] Neumann, Elena, et al. “Adipokines in bone disease.” Nature Reviews Rheumatology, Vol. 12, No. 5, 2016, pp.
296-302.
[12] Vuolteenaho, Katriina, et al. “Leptin enhances synthesis of proinflammatory mediators in human osteoarthritic
cartilage-mediator role of NO in leptin-induced, IL-6, and IL-8 production.” Mediators of Inflammation, Vol.
2009, 2009.
[13] Chilliard, Y., C. Delavaud, and M. Bonnet. “Leptin expression in ruminants: nutritional and physiological
regulations in relation with energy metabolism.” Domestic Animal Endocrinology, Vol. 29, No. 1, 2005, pp. 3-22.
[14] Menendez, C., et al. “TSH stimulates leptin secretion by a direct effect on adipocytes.” Journal of
Endocrinology, Vol. 176, No. 1, 2003, pp. 7-12.
[15] Rajala, Michael W., et al. “Regulation of resistin expression and circulating levels in obesity, diabetes, and
fasting.” Diabetes, Vol. 53, No. 7, 2004, pp. 1671-79.
[16] Steppan, Claire M., et al. “The hormone resistin links obesity to diabetes.” Nature, Vol. 409, No. 6818, 2001,
pp. 307-12.
[17] Lazar, M.A. “Resistin-and obesity-associated metabolic diseases.” Hormone and Metabolic Research, Vol. 39,
No. 10, 2007, pp. 710-16.
[18] Iglesias, Pedro, et al. “Serum concentrations of adipocytokines in patients with hyperthyroidism and
hypothyroidism before and after control of thyroid function.” Clinical Endocrinology, Vol. 59, No. 5, 2003, pp.
621-29.
[19] Yaturu, Subhashini, Susan Prado, and Sidney R. Grimes. “Changes in adipocyte hormones leptin, resistin, and
adiponectin in thyroid dysfunction.” Journal of Cellular Biochemistry, Vol. 93, No. 3, 2004, pp. 491-96.
[20] Krassas, Gerasimos E., et al. “Resistin levels in hyperthyroid patients before and after restoration of thyroid
function: relationship with body weight and body composition.” European Journal of Endocrinology, Vol. 153,
No. 2, 2005, pp. 217-21.
[21] Bossowski, Artur, et al. “Analysis of serum adiponectin, resistin and leptin levels in children and adolescents
with autoimmune thyroid disorders.” Journal of Pediatric Endocrinology and Metabolism, Vol. 23, No. 4, 2010,
pp. 369-77.
[22] Hedayati, Mehdi, et al. “Serum level of resistin in patients with hyperthyroidism and hypothyroidism.” Zahedan
Journal of Research in Medical Sciences, Vol. 16, No. 11, 2013.
[23] SAS Institute Inc.: SAS 9.1 (9.1 TS1M0) [software]. 2012 [cited 2017 Sep 14]. Available from: http://support.
sas.com/documentation/onlinedoc/91pdf/index.html.
[24] Chen, Yanyan, et al. “Changes in profile of lipids and adipokines in patients with newly diagnosed hypothyroidism
and hyperthyroidism.” Scientific Reports, Vol. 6, 2016.
[25] Ibrahim, Maher K. “Association between leptin hormone and thyroid hormone levels in hypothyroid, hyperthyroid
and euthyroid subjects.” Frontiers in Biomedical Sciences, Vol. 1, No. 2, pp. 39-44.
[26] Nakamura, Tomoatsu, et al. “Association of hyperthyroidism with serum leptin levels.” Metabolism, Vol. 49,
No. 10, 2000, pp. 1285-88.
[27] Diekman, M.J.M., et al. “Thyroid hormones modulate serum leptin levels: observations in thyrotoxic and
hypothyroid women.” Thyroid, Vol. 8, No. 12, 1998, pp. 1081-86.
Al-Hindawi Sahar H Int J Med Res Health Sci 2018, 7(1): 40-47
47
[28] Medina-Gomez, Gema, Rosa-Maria Calvo, and Maria-Jesus Obregón. “T3 and Triac inhibit leptin secretion
and expression in brown and white rat adipocytes.” Biochimica et Biophysica Acta (BBA)-Molecular and Cell
Biology of Lipids, Vol. 1682, No. 1, 2004, pp. 38-47.
[29] Ortiga-Carvalho, T.M., et al. “The role of leptin in the regulation of TSH secretion in the fed state: In vivo and
in vitro studies.” Journal of Endocrinology, Vol. 174, No. 1, 2002, pp. 121-25.
[30] Rosenbaum, Michael, et al. “Low-dose leptin reverses skeletal muscle, autonomic, and neuroendocrine
adaptations to maintenance of reduced weight.” Journal of Clinical Investigation, Vol. 115, No. 12, 2005, p.
3579.
[31] Araujo, Renata L., and Denise P. Carvalho. “Bioenergetic impact of tissue-specific regulation of iodothyronine
deiodinases during nutritional imbalance.” Journal of Bioenergetics and Biomembranes, Vol. 43, No. 1, 2011,
pp. 59-65.
[32] Eke Koyuncu, Ceren, et al. “Serum resistin and insulin-like growth factor-1 levels in patients with hypothyroidism
and hyperthyroidism.” Journal of Thyroid Research, Vol. 2013, 2013.
[33] Krassas, G.E., et al. “Resistin levels are normal in hypothyroidism and remain unchanged after attainment of
euthyroidism: Relationship with insulin levels and anthropometric parameters.” Journal of Endocrinological
Investigation, Vol. 29, No. 7, 2006, pp. 606-12.
[34] Roef, Greet, et al. “Body composition and metabolic parameters are associated with variation in thyroid hormone
levels among euthyroid young men.” European Journal of Endocrinology, Vol. 167, No. 5, 2012, pp. 719-26.
Thank you for copying data from http://www.arastirmax.com